Article Details

Sumitovant Biopharma Announces Myovant Sciences Positive One-Year Data from Phase 3 ...

Retrieved on: 2021-01-26 19:30:00

Tags for this article:

Click the tags to see associated articles and topics

Sumitovant Biopharma Announces Myovant Sciences Positive One-Year Data from Phase 3 .... View article details on hiswai:

Excerpt

NEW YORK, LONDON,, Jan. 26, 2021 (GLOBE NEWSWIRE) -- Sumitovant Biopharma Ltd., a majority shareholder of Myovant Sciences (NYSE: ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up